期刊论文详细信息
BMC Psychiatry
Thyroid function in clinical subtypes of major depression: an exploratory study
Per Bech1  George St Kaprinis2  Philippos Grammaticos3  Apostolos Iacovides2  Konstantinos N Fountoulakis4 
[1] Frederiksborg General Hospital Department of Psychiatry, Hillerod Denmark;3rd Department of Psychiatry, Aristotle University of Thessaloniki, University Hospital AHEPA, Thessaloniki Greece;Laboratory of of Nuclear Medicine, Aristotle University of Thessaloniki, University Hospital AHEPA, Thessaloniki Greece;Laboratory of Psychophysiology, 3rd Department of Psychiatry, Aristotle University of Thessaloniki, University Hospital AHEPA, Thessaloniki Greece
关键词: autoimmune disorders.;    psychoneuroendocrinology;    thyroid function;    depression;   
Others  :  1125141
DOI  :  10.1186/1471-244X-4-6
 received in 2003-09-15, accepted in 2004-03-15,  发布年份 2004
PDF
【 授权许可】

   
2004 Fountoulakis et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

【 预 览 】
附件列表
Files Size Format View
20150216100537279.pdf 386KB PDF download
【 参考文献 】
  • [1]Staner L, De La Fuente JM, Kerkhofs M, Linkowski P, Mendlewicz J: Biological and clinical features of recurrent brief depression: a comparison with major depressed and healthy subjects. Journal of Affective Disorders 1992, 26:241-245.
  • [2]Legros S, Mendlewicz J, Wybran J: Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders. Eur Arch Psychiatry Neurol Sci 1985, 235:9-11.
  • [3]Rao ML, Ruhrmann S, Retey B, Liappis N, Fuger J, Kraemer M, Kasper S, Möller HJ: Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome. Pharmacopsychiatry 1996, 29:180-186.
  • [4]Iacovides A, Fountoulakis KN, Grammaticos P, Ierodiakonou C: Difference in symptom profile between generalized anxiety disorder and anxiety secondary to hyperthyroidism. International Journal of Psychiatry in Medicine 2000, 30:71-81.
  • [5]Ordas DM, Labbate LA: Routine screening of thyroid function in patients hospitalized for major depression or dysthymia? Annals of Clinical Psychiatry 1995, 7:161-165.
  • [6]Joffe RT, Sokolov ST: Thyroid hormones, the brain, and affective disorders. Crit Rev Neurobiol, 1994, 8:45-63.
  • [7]Roth M: The phenomenology of depressive states. Can Psychiatr Assoc J 1959, 4(suppl):32-54.
  • [8]Van Praag HM, Uleman AM, Spitz JC: The Vital Syndrome Interview. Psychiatr Neurol Neurochir 1965, 68:329-349.
  • [9]Overall JE, Hollister LE, Johnson M: Nosology of Depression and Differential Response to Drugs. JAMA 1966, 195:946-950.
  • [10]Fountoulakis KN, Iacovides A, Nimatoudis I, Kaprinis G, Ierodiakonou Ch: Comparison of the Diagnosis of Melancholic and Atypical Features According to DSM-IV and Somatic Syndrome According to ICD-10 In Patients Suffering from Major Depression. European Psychiatry 1999, 14:426-434.
  • [11]APA: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, DSM-IV. Washington DC, American Psychiatric Press; 1994.
  • [12]WHO: The ICD-10 Classification of Mental and Behavioural Disorders-Diagnostic Criteria for Research. Geneva; 1993.
  • [13]Liebowitz MR, Quitkin FM, Stewart J, McGrath PP, Harrison W, Markowitz J, Rabkin J, Tricamo E, Goetz D, D Klein: Antidepressant Specificity in Atypical Depression. Archives of General Psychiatry 1988, 45:129-137.
  • [14]Sargant W: Some Newer Drugs in the Treatment of Depression and their Relation to Other Somatic Treatments. Psychosomatics 1960, 1:14-17.
  • [15]Dally PJ, Rohde P: Comparison of Antidepressant Drugs in Depressive Illnesses. Lancet 1961, 1:18-20.
  • [16]Fountoulakis K, Fotiou F, Iacovides A, Goulas A, Tsolaki M, Ierodiakonou Ch: Changes in Pupil Reaction to Light in Melancholic patients. International Journal of Psychophysiology 1999, 31:121-128.
  • [17]Gold PW, Chrousos GP: Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 2002, 7:254-275.
  • [18]Elenkov IJ, Chrousos GP: Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 2002, 966:290-303.
  • [19]Carta MG, Hardoy MC, Boi MF, Mariotti S, Carpiniello B, Usai P: Association between panic disorder, major depressive disorder and celiac disease: a possible role of thyroid autoimmunity. J Psychosom Res 2002, 53:789-793.
  • [20]Carta MG, Hardoy MC, Usai P, Carpiniello B, Angst J: Recurrent brief depression in celiac disease. J Psychosom Res 2003, 55:573-574.
  • [21]Wing JK, Babor T, Brugha T: SCAN: Schedules for Clinical Assessment in Neuropsychiatry. Archives of General Psychiatry 1990, 47:589-593.
  • [22]WHO: Schedules for Clinical Assessment in Neuropsychiatry-SCAN version 2.0) Greek Version. Edited by Mavreas V. Athens, Research University Institute for Mental Health; 1995.
  • [23]Loranger AW, Sartorious N, Andreoli Al: The World Health Organisation/Alcohol, Drug Abuse and Mental Health Administration International Pilot Study of Personality Disorders. Archives of General Psychiatry 1994, 51:215-224.
  • [24]WHO: International Personality Disorders Examination. Geneva; 1995.
  • [25]Fountoulakis KN, Iacovides A, Kaprinis G, Ierodiakonou Ch: World Health Organisation: International Personality Disorders Examination, Greek Edition. Thessaloniki Greece; unpublished
  • [26]Fountoulakis KN, Iacovides A, Ioannidou Ch, Bascialla F, Nimatoudis I, Kaprinis G, Janca A, Dahl A: Reliability and cultural applicability of the Greek version of the International Personality Disorders Examination. BMC Psychiatry 2002, 2:6. BioMed Central Full Text
  • [27]Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
  • [28]Williams J: A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 1988, 45:742-747.
  • [29]Hamilton M: The Assessment of Anxiety States by Rating. British Journal of Medical Psychology. 1959, 32:50-55.
  • [30]APA: Diagnostic and Statistical Manual of Mental Disorders. 4th (DSM-IV) edition. Washington DC; 1994:32.
  • [31]Mariotti S, Caturegli P, Piccolo P, Barbesino G, Pinchera A: Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab 1990, 71:661-669.
  • [32]Musselman DL, Nemeroff CB: Depression and endocrine disorders: focus on the thyroid and adrenal system. Br J Psychiatry 1996, (suppl)(30):123-128.
  • [33]Sullivan GM, Hatterer JA, Herbert J: Low Levels of Transthyretin in the CSF of Depressed Patietns. American Journal of Psychiatry 1999, 156:710-715.
  • [34]Bauer MS, Whybrow PC, Winokur A: Rapid Cycling Bipolar Affective Disorder I: Association with Grade I Hypothyroidism. Archives of General Psychiatry 1990, 47:427-432.
  • [35]Schindler BA: Stress, affective disorders, and immune function. Medical Clinics Of North America 1985, 69:585-597.
  • [36]Jankovic BD: Neural tissue hypersensitivity in psychiatric disorders with immunologic features. J Immunol 1985, 135(2suppl):853s-857s.
  • [37]Kaptein EM: Clinical Application of Free Thyroxine Determinations. Clinical and Laboratory Medicine 1993, 13:653-672.
  • [38]Fava M, Labbate LA, Abraham ME, Rosenbaum JF: Hypothyroidism and hyperthyroidism in major depression revisited. Journal of Clinical Psychiatry 1995, 56:186-192.
  • [39]Joffe R, Segal Z, Singer W: Change in thyroid hormone levels following response to cognitive therapy for major depression. American Journal Of Psychiatry 1996, 153:411-413.
  • [40]Haggerty JJ, Silva SG, Marquardt M, Mason GA, Chang HY, Evans DL, Golden RN, Pedersen C: Prevalence of antithyroid antibodies in mood disorders. Depression And Anxiety 1997, 5:91-96.
  • [41]Pop VJ, Maartens LH, Leusink G, vanSon MJ, Knottnerus AA, Ward AM, Metcalfe R, Weetman AP: Are autoimmune thyroid dysfunction and depression related? Journal Of Clinical Endocrinology And Metabolism 1998, 83:3194-3197.
  • [42]Harris B, Fung H, Johns S, Kologlu M, Bhatti R, McGregor AM, Richards CJ, Hall R: Transient post-partum thyroid dysfunction and postnatal depression. Journal Of Affective Disorders 1989, 17:243-249.
  • [43]Joffe RT: Antithyroid antibodies in major depression. Acta Psychiatrica Scandinavica 1987, 76:598-599.
  • [44]Howland RH: Thyroid dysfunction in refractory depression: implications for pathophysiology and treatment. Journal of Clinical Psychiatry 1993, 54:47-54.
  • [45]Rao ML, Vartzopoulos D, Fels K: Thyroid function in anxious and depressed patients. Pharmacopsychiatry 1989, 22:66-70.
  • [46]Nemeroff CB: Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal. Journal of Clinical Psychiatry 1989, 50 Suppl:13-20.
  • [47]Maes M, D'Hondt P, Blockx P, Cosyns P: A further investigation of basal HPT axis function in unipolar depression: effects of diagnosis, hospitalization, and dexamethasone administration. Psychiatry Research 1994, 51:185-201.
  • [48]Bunevicius R, Kazanavicius G, Telksnys A: Thyrotropin response to TRH stimulation in depressed patients with autoimmune thyroiditis. Biological Psychiatry 1994, 36:543-547.
  • [49]Banki CM, Vojnik M, Arato M, Papp Z, Kovacs Z: Dexamethasone suppression and multiple hormonal responses (TSH, prolactin and growth hormone) to TRH in some psychiatric disorders. European Archives of Psychiatry and Neurological Sciences 1985, 235:32-37.
  • [50]Rupprecht R, Rupprecht C, Rupprecht M, Noder M, Mahlstedt J: Triiodothyronine, thyroxine, and TSH response to dexamethasone in depressed patients and normal controls. Biological Psychiatry 1989, 25:22-32.
  • [51]Gewirtz GR, Malaspina D, Hatterer JA, Feureisen S, Klein D, Gorman JM: Occult thyroid dysfunction in patients with refractory depression. American Journal Of Psychiatry 1988, 145:1012-1014.
  • [52]Marchesi C, Chiodera P, DeRisio C, Dassò L, Govi AM, DeFerri A, Piagneri B, Minelli R, Bianconi L, Gnudi A: Dopaminergic control of TSH secretion in endogenous depression. Psychiatry Research 1988, 25:277-282.
  • [53]Nemeroff CB, Simon JS, Haggerty JJ, Evans DL: Antithyroid antibodies in depressed patients. American Journal Of Psychiatry 1985, 142:840-843.
  • [54]Kjellman BF, Ljunggren JG, Beck-Friis J, Wetterberg L: Effect of TRH on TSH and prolactin levels in affective disorders. Psychiatry Research 1985, 14:353-363.
  • [55]Haggerty JJ, Stern RA, Mason GA, Beckwith J, Morey CE, Prange AJ: Subclinical hypothyroidism: a modifiable risk factor for depression? American Journal Of Psychiatry 1993, 150:508-510.
  • [56]Haggerty JJ, Evans DL, Golden RN, Pedersen CA, Simon JS, Nemeroff CB: The presence of antithyroid antibodies in patients with affective and nonaffective psychiatric disorders. Biological Psychiatry 1990, 27:51-60.
  • [57]O'Donnell M, Silove D, Wakefield D: Current perspectives on immunology and psychiatry. Australian And New Zealand Journal Of Psychiatry 1988, 22:366-382.
  • [58]Stein MB, Uhde TW: Autoimmune thyroiditis and panic disorder. American Journal Of Psychiatry 1989, 146:259-260.
  • [59]Loosen PT: The TRH-induced TSH response in psychiatric patients: a possible neuroendocrine marker. Psychoneuroendocrinology 1985, 10:237-260.
  • [60]Jackson IM: The thyroid axis and depression. Thyroid 1998, 8:951-956.
  • [61]Jackson IM: The thyroid axis and depression. Thyroid 1998, 8:951-956.
  • [62]Sagud M, Pivac N, Muck-Seler D, Jakovljevic M, Mihaljevic-Peles A, Korsic M: Effects of sertraline treatment on plasma cortisol, prolactin and thyroid hormones in female depressed patients. Neuropsychobiology 2002, 45:139-143.
  • [63]Konig F, Hauger B, vonHippel C, Wolfersdorf M, Kaschka WP: Effect of paroxetine on thyroid hormone levels in severely depressed patients. Neuropsychobiology 2000, 42:135-138.
  • [64]Szuba MP, O'Reardon JP, Rai AS, Snyder-Kastenberg J, Amsterdam JD, Gettes DR, Wassermann E, Evans DL: Acute mood and thyroid stimulating hormone effects of transcranial magnetic stimulation in major depression. Biological Psychiatry 2001, 50:22-27.
  • [65]Orth DN, Shelton RC, Nicholson WE, Beck-Peccoz P, Tomarken AJ, Persani L, Loosen PT: Serum thyrotropin concentrations and bioactivity during sleep deprivation in depression. Archives of General Psychiatry 2001, 58:77-83.
  • [66]David MM, Owen JA, Abraham G, Delva NJ, Southmayd SE, Wooltorton E, Lawson JS: Thyroid function and response to 48-hour sleep deprivation in treatment-resistant depressed patients. Biological Psychiatry 2000, 48:323-326.
  • [67]vanWest D, Maes M: Activation of the inflammatory response system: A new look at the etiopathogenesis of major depression. Neuroendocrinology Letters 1999, 20:11-17.
  • [68]Duval F, Mokrani MC, Bailey P, Correa H, Diep TS, Crocq MA, Macher JP: Thyroid axis activity and serotonin function in major depressive episode. Psychoneuroendocrinology 1999, 24:695-712.
  • [69]Fountoulakis KN, Fotiou F, Iacovides A, Karamouzis M, Goulas A, Demetriadou A, Kaprinis G: Relationship between pupillometric findings, DST and melancholia. Acta Psychiatrica Belgica in press
  • [70]Frye MA, Dunn RT, Gary KA, Kimbrell TA, Callahan AM, Luckenbaugh DA, Cora-Locatelli G, Vanderham E, Winokur A, Post RM: Lack of correlation between cerebrospinal fluid thyrotropin-releasing hormone (TRH) and TRH-stimulated thyroid-stimulating hormone in patients with depression. Biological Psychiatry 1999, 45:1049-1052.
  • [71]Harris B: Postpartum depression and thyroid antibody status. Thyroid 1999, 9:699-703.
  • [72]Pedersen CA: Postpartum mood and anxiety disorders: a guide for the nonpsychiatric clinician with an aside on thyroid associations with postpartum mood. Thyroid 1999, 9:691-697.
  • [73]Kent GN, Stuckey BG, Allen JR, Lambert T, Gee V: Postpartum thyroid dysfunction: clinical assessment and relationship to psychiatric affective morbidity. Clinical Endocrinology 1999, 51:429-438.
  • [74]Harris B, Oretti R, Lazarus J, Parkes A, John R, Richards C, Newcombe R, Hall R: Randomised trial of thyroxine to prevent postnatal depression in thyroid-antibody-positive women. Br Psychiatry 2002, 180:327-330.
  • [75]Lucas A, Pizarro E, Granada ML, Salinas I, Sanmarti A: Postpartum thyroid dysfunction and postpartum depression: are they two linked disorders? Clinical Endocrinology 2001, 55:809-814.
  • [76]Kuijpens JL, Vader HL, Drexhage HA, Wiersinga WM, vanSon MJ, Pop VJ: Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum. European Journal of Endocrinology 2001, 145:579-584.
  文献评价指标  
  下载次数:6次 浏览次数:12次